Tag Archives: Onconova Therapeutics

Our MDS “white knight” moves forward to the finish!

We all like happy endings and this is the best kind! Just last week, rigosertib, a  myelodysplastic syndrome (MDS) drug with tremendous potential, received sizable funding – the kind that will get it across and beyond the finish line. It’s a great story, … Continue reading

Rate this:

Posted in Blood Cancer Research, General SF Chapter | Tagged , , , , , | Leave a comment

Finding a new therapy for MDS

Today there are just a handful of treatments for patients with myelodysplastic syndrome (MDS), a condition that involves ineffective blood cell production. Patients often develop severe anemias and require frequent blood transfusions. In the worst case scenario, MDS can evolve into … Continue reading

Rate this:

Posted in Blood Cancer Research, LLS Partners | Tagged , , , , , | Leave a comment